Company news
Avicanna Inc news in 2019
Avicanna Inc's news releases, calls and decks from 2019, newest first.
Avicanna Enters Into USD$5 Million Revolving Credit Facility
December 27, 2019
Avicanna to Host Key Opinion Leader Meeting on the Use of Cannabinoids for the Treatment of Pain and Epilepsy
December 6, 2019
Avicanna Receives DTC Eligibility for Common Shares on OTCQX
December 5, 2019
Avicanna to Supply UK Market with Cannabis-Based Medicinal Products Through Distribution Agreement with the LYPHE Group
December 3, 2019
Avicanna's Rho Phyto Branded Products to be Available in California
December 1, 2019
Avicanna Announces Option to Purchase Newly Formed US Cannabis Operator
November 26, 2019
Avicanna Reports Third Quarter 2019 Financial Results
November 14, 2019
Avicanna Announces Voluntary Lock-Up Agreements for Key Insiders and Separation of CEO and Chairman Roles
October 29, 2019
Avicanna (TSX: AVCN) Completes First Commercial Exports of CBD to South Africa and the United Kingdom
October 24, 2019
Avicanna Announces Retail Launch of Pura Earth Derma-Cosmetics with Initial Roll-Out in Colombia
October 21, 2019
Avicanna (TSX: AVCN) Announces Receipt of the First Colombian USDA Organic Certification for its Hemp Cultivation and Registration of 15 Additional Genetics
October 18, 2019
Avicanna Commences Trading on the OTCQX Market in the United States
October 15, 2019
Avicanna (TSX: AVCN) Announces First Commercial Sale of the Pura Earth Derma-Cosmetics line of CBD Products
October 2, 2019
Avicanna (TSX: AVCN) to Open its Next Phase Extraction Facility in Colombia's Free Trade Zone
September 30, 2019
Avicanna (TSX: AVCN) Aras Azadian, CEO & Co-Founder to speak at the 12th Annual International Natural & Organic Cosmetics Conference About Organic CBD Skin Care and Pura Earth(TM) in Berlin, Germany
September 23, 2019
Avicanna (TSX: AVCN) Enters an Exclusive Research Agreement with the University of Guelph for Proprietary Cannabinoid-based Products and Formulations to Treat Psychiatric Disorders
September 13, 2019
Avicanna (TSX: AVCN) Further Strengthens its Position as a Canadian Leader in Cannabinoid Based Research and Development with Expansion of University of Toronto Collaboration and Execution of University of Guelph Research Agreement
August 30, 2019
Avicanna (TSX: AVCN) Completes its First Exportation of Cannabinoids from Colombia to Canada for Scientific Purposes
August 23, 2019
Avicanna Secures Canadian Cannabinoid Research Licence at its Headquarters in Toronto's Discovery District
August 19, 2019
Avicanna Reports Second Quarter 2019 Financial Results
August 14, 2019
Avicanna announces joint venture with Sigma Analytical Services Inc., to establish the first GMP/GLP level cannabis quality assurance laboratory in South America
August 8, 2019
View from the C-Suite: Aras Azadian, Chief Executive Officer, Avicanna Inc., tells his company's story. Filmed on July 18, 2019
August 6, 2019
Avicanna Announces Commencement of Clinical Trials for Derma-Cosmetics
July 24, 2019
Avicanna Commences Trading on the TSX Under the Symbol "AVCN"
July 18, 2019
Avicanna Inc. Opens the Market
July 17, 2019